These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1997079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 6. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM, Virgini-Magalhães CE, Lencastre Sicuro F, Bottino DA, Bouskela E.
    Angiology; 2008 Jun; 59(5):549-58. PubMed ID: 18388031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pentoxifylline therapy for chronic claudication: are patients dependent on therapy?
    Johnson WC, Watkins MT, Hamilton J, Baldwin D, Walker N.
    Surgery; 1994 Jun; 115(6):735-9. PubMed ID: 8197567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, De Sanctis MT, Incandela L, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Bavera P, Ippolito E.
    Angiology; 2002 Jun; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication.
    King S, Vanicek N, Mockford KA, Coughlin PA.
    Clin Biomech (Bristol, Avon); 2012 Oct; 27(8):845-51. PubMed ID: 22663776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication.
    Agrawal K, Eberhardt RT.
    Cardiol Clin; 2015 Feb; 33(1):111-37. PubMed ID: 25439335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Randomized study of tolerability, safety and efficacy of Pletax in intermittent claudication].
    Kazantsev AN, Goriunov SV, Ershova OB, Erofeeva SB, Gurgenian EV.
    Angiol Sosud Khir; 2021 Feb; 27(1):7-16. PubMed ID: 33825723
    [Abstract] [Full Text] [Related]

  • 18. A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly.
    Ciocon JO, Galindo-Ciocon D, Galindo DJ.
    Angiology; 1997 Mar; 48(3):237-40. PubMed ID: 9071199
    [Abstract] [Full Text] [Related]

  • 19. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    Indian Heart J; 1989 Mar; 41(2):127-33. PubMed ID: 2744799
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.